FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula I: 
or its pharmacologically acceptable salts, where n equals 1, 2 or 3; and values of R1, R2, R3, R4, R3', R10, R11 are given in i.1 of formula.
EFFECT: compounds I have ability to inhibit release and/or synthesis of β-amyloid peptide, which allows to apply them in pharmaceutical composition.
25 cl, 3 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSECTICIDE ANTHRANYLAMIDES | 2001 |
|
RU2278852C2 |
| USE OF EP4 RECEPTOR ANTAGONIST IN TREATMENT OF CARTILAGE DISEASE | 2014 |
|
RU2663620C2 |
| SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES | 2006 |
|
RU2451009C2 |
| TABLET COMPOSITION | 1989 |
|
RU2093028C1 |
| AMIDOMETHYL SUBSTITUTED DERIVATIVES OF 1-(CARBOXYALKYL)CYCLOPENTYLCARBONYLAMINOBENZAZEPIN-N-ACETIC ACID, METHOD AND INTERMEDIATE MATERIAL FOR OBTAINING THEM AND MEDICINAL AGENTS CONTAINING THESE COMPOUNDS | 2004 |
|
RU2368601C2 |
| NEW PHTHALAZINONE DERIVATIVES AS AURORA A KINASE INHIBITORS | 2005 |
|
RU2397166C2 |
| 2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2220968C2 |
| BRIDGED N-CYCLYC SULPHONAMIDO-INHIBITORS OF GAMMA-SECRETASE | 2006 |
|
RU2422443C2 |
| STEREOISOMER COMPOUNDS AND METHODS OF TREATING GASTROINTESTINAL DISORDERS AND CENTRAL NERVOUS SYSTEM DISORDERS | 2005 |
|
RU2374244C2 |
| CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF | 2016 |
|
RU2729636C2 |
